Hyperion Therapeutics

Hyperion Therapeutics

Amgen Completes Acquisition of Horizon Therapeutics.

Launch date
Market cap
-
Enterprise valuation
€1.0b (Public information from Mar 2015)
Dublin County Dublin (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$17.5m

Late VC
N/A

$7.5m

Debt
N/A

N/A

IPO
*
N/A

$59.7m

Post IPO Equity

$1.1b

Valuation: $1.1b

Acquisition
Total Funding€70.5m

Recent News about Hyperion Therapeutics

Edit